FDA Releases Guidance on Regulating Living Autologous Cells for Structural Repair

Summary

The FDA has made available a new guidance document outlining its approach to regulating living autologous cells, also known as MAS cells, which are manipulated ex vivo for structural repair or reconstruction, and is now open for public comment.